Eagle Bay Advisors LLC purchased a new position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,691 shares of the medical research company’s stock, valued at approximately $210,000. [...]
Eagle Bay Advisors LLC Makes New $210,000 Investment in Edwards Lifesciences Corporation $EW
